Trial Profile
Immunogenicity of PPSV-23 After PCV-13 Vaccination in Adult Asthmatic Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Nov 2021
Price :
$35
*
At a glance
- Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary) ; Pneumococcal vaccine; Pneumococcal vaccine
- Indications Pneumococcal infections
- Focus Pharmacodynamics
- 05 Jan 2021 Status changed from recruiting to completed.
- 16 Mar 2020 Results (N=15), assessing the effect of priming with conjugate PCV13 vaccine prior to PPSV23 to elicits T-cell dependent durable immune responses, published on 2020 Annual Meeting of the American Academy of Allergy, Asthma and Immunology
- 04 Jan 2020 Planned End Date changed from 1 Dec 2019 to 1 Dec 2020.